Bioterrorism: Market Research Report

July 2009 | 273 pages | ID: B82C64F3AD9EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Bioterrorism in Millions of US$.

The report provides separate comprehensive analytics for the US, Europe, Asia, and Middle East.

Annual forecasts are provided for each region for the period of 2001 through 2015.

The report profiles 66 companies including many key and niche players worldwide such as Acambis Plc., AVI BioPharma, Inc., Blücher Gmbh, Evogen, Inc., Human Genome Sciences Inc., ICX Technologies, Inc., ILC Dover LP, Medarex, Inc., Northrop Grumman Corporation, PharmAthene, Inc., Scott Health & Safety, Smiths Detection, The Baker Company, Universal Detection Technology and Universal Detection Technology.

Market data and analytics are derived from primary and secondary research.

Company profiles are mostly extracted from URL research and reported select online sources.

Contents

I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INTRODUCTION

Current & Future Analysis
Market Overview

2. UNDERSTANDING BIOTERRORISM

A Brief Historic Account on Bioterrorism
Why Biological Agents?
An Ideal Biological Weapon Candidate
Bioterrorism is Easy: The Myth!
Biological Agents/Diseases with Potential for Biological Warfare
Properties of Biological Agents with Potential for Use as Weapons of Mass Destruction
Anthrax
The Anthrax History
Types of Anthrax
Inhalational Anthrax
Cutaneous Anthrax
Gastrointestinal Anthrax
The Anthrax Symptoms, Treatment, and Vaccination
Smallpox
The Smallpox History
Plague
The Plague History
Types of Plague
Bubonic Plague
Pneumonic Plague
Botulism
Tularemia
The Tularemia History
Viral Hemorrhagic Fevers
Ebola Hemorrhagic Fever
Marburg Hemorrhagic Fever
Lassa Hemorrhagic Fever
Q Fever
Brucellosis
Ricin
Others

3. MODES OF DELIVERY

Aerosol Dissemination
Water Contamination
Food Contamination
Insect Vectors
Other

4. BIOTERRORISM DEFENSE PRODUCTS AND DETECTION EQUIPMENT

Detection Equipment
Point Detection Systems
Standoff Detection Systems
Passive Standoff Detection Systems
Defense Products
Vaccines
Personal Protective Equipment

5. RECENT INDUSTRY ACTIVITY

Sanofi Pasteur Acquires Acambis
PharmAthene Acquires Avecia Biodefense Vaccines Business
ICx Technologies Completes S3I Acquisition
Johnson & Johnson to Acquire Omrix
Emergent BioSolutions Enters into Joint Venture with Ninebio Sdn Bhd
Alert B&C, Frontline Robotics, and Dragon Securite Sign MoU
Universal Detection and Kadinuo Sign Agreement
PharmAthene Signs Marketing Pact with Medison for Israeli Market
PharmAthene Forms Alliance with Panacea Biotec
Innovative Biosensors and Universal Detection Plan Collaboration
Acambis Wins Government Contract for ACAM2000™ Smallpox Vaccine
Crucell, Integrated BioTherapeutics Win NIAID Funding for Vaccine Development
Universal Detection Secures Repeat Order for Biodetection Kits
Universal Detection Secures Repeat Order for Biodetection Training Equipment
Universal Detection Secures and Completes Contract
Hawaii Emergency Medical Services Orders Simulation and Bio-Detection Kits
IR BioSciences Raises Financing for Drug Development
AVI BioPharma Files IND for Marburg
ICx Technologies Completes GHC Technologies Acquisition
NanoSensors to Acquire DKL International
Allen-Vanguard to Acquire Hazard Management Solutions
PharmAthene Announces Reverse Merger to Acquire Healthcare Acquisition
CytoGenix Enters into CRADA with USAMRIID
Advanced Life Sciences Announces Collaboration with NIAID
U.S. BioDefense to Receive Exclusive License from Shine Holdings
Emergent BioSolutions Signs Agreement to License VaxImmune
Universal Detection Signs Distribution Agreement with ADVNT
Universal Detection Secures Gulf Security Order for Detection Kits
Dycor Technologies Wins Rheinmetall Landsystems Contract
AVI BioPharma Secures Bioterrorism Response Therapies Contracts
Emergent BioSolutions Wins HHS Anthrax Biodefense Contract
Nanotherapeutics Wins Anti-Bioterrorism Drug Contract from NIAID/ BARDA
SRI International Secures Contract for Anti-Biological Threat Drugs from DTRA
Universal Detection Completes Foot Locker Order for Bioterrorism Detection Kits
PharmAthene Wins HHS Biodefense Contract
Ibis Biosciences Receives Four New Contracts from Government
Universal Detection Receives Guaranteed Order from SSI
Ichor Receives Navy Contract for Vaccine Development
PharmAthene Receives Contract to Develop Anthrax Anti-Toxin
General Dynamics Canada Secures Contract from Canadian Forces
Universal Detection Commences R&D for Portable Anthrax Detector
BioFactura Completes Initial Clinical Testing

6. PRODUCT LAUNCHES

Smiths Detection Introduces SmartBio™ Biological Agents Detector
Safe Life Launches Triosyn Disposable Respirators
ICx Unveils Integrated System for CBR Threat Detection, SafeAir™
Innovative Biosensors Unveils BioFlash Biological Detector
Lawrence Laboratory Develops Biological, Chemical Agent Detection Machine

7.FOCUS ON SELECT PLAYERS

Acambis Plc (UK)
AVI BioPharma, Inc. (USA)
Blucher Gmbh (Germany)
Evogen, Inc. (USA)
Human Genome Sciences Inc. (USA)
ICX Technologies, Inc. (USA)
ILC Dover LP (USA)
Medarex, Inc. (USA)
Northrop Grumman Corporation (USA)
PharmAthene, Inc. (USA)
Scott Health & Safety (USA)
Smiths Detection (USA)
The Baker Company (USA)
Universal Detection Technology (USA)

8. GLOBAL MARKET PERSPECTIVE

Table 1. World Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment by Geographic Region – US, Europe, Asia (Including Japan), and Middle East Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

Table 2. World Historic Review for Bioterrorism Detection Equipment by Geographic Region – US, Europe, Asia (Including Japan), and Middle East Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2001 through 2015 (includes corresponding Graph/Chart)

Table 3. World 10-Year Perspective for Bioterrorism Detection Equipment Market by Geographic Region – Percentage Share Breakdown of Dollar Revenue for US, Europe, Asia (Including Japan), and Middle East Markets for Years 2006, 2009, and 2015 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. MARKET ANALYSIS

A Case of Undue Importance
Market Drivers
Market Dampers
Investment Bottlenecks
Legislative Bottlenecks
Government Biodefense Funding
The Federal Biological Weapons Prevention and Defense Funding

Table 4. The US Federal Government Spending on Bioweapons Prevention and Defense – Allocation of Funds in US$ Million by Department/Agency from FY2001 to FY2007 (includes corresponding Graph/Chart)

Table 5. The US Federal Government Spending on Bioweapons Prevention and Defense – Percentage Share Breakdown of Funds Allocation by Department/Agency for FY2001 and FY2007 (includes corresponding Graph/Chart)

Table 6. The US Federal Funding for the Department of Health and Human Services by its Constituent Agencies and Offices in US$ Million from FY2001-FY2007 (Including Requested Funding for the Year 2007) (includes corresponding Graph/Chart)

The RDT&E Biodefense Funding

Table 7. Biodefense Funding for Research, Development, Testing and Evaluation (RTD&E) by Agency/Department in US$ Million from FY2001 to FY2007

Biodefense Prevention Funding

Table 8. Federal Biodefense Prevention Funding in US$ Million from FY2001 to FY2007 (includes corresponding Graph/Chart)

Recent Awards for Biodefense Preparedness
Government Biodefense Initiatives
Project BioShield
Pandemic and All-Hazards Preparedness Act
Public Health Security and Bioterrorism Preparedness and Response Act
Government Departments / Agencies
The Department of Health and Human Services
The National Institutes of Health
The Centers for Disease Control and Prevention
The CDC Classification
The CDC Regulated Shipment Agents
The Department of Defense

B. MARKET ANALYTICS

Table 9. US Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

Table 10. US Historic Review for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart)

Table 11. US Recent Past, Current & Future Analysis for Bioterrorism Vaccines Market – Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

Table 12. US Historic Review for Bioterrorism Vaccines Market – Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart)

2. EUROPE

Market Analysis

Table 13. European Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

Table 14. European Historic Review for Bioterrorism Detection Equipment Market - Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart)

3. ASIA

A. MARKET ANALYSIS

ASEAN and Canada Forge Ties to Combat Bioterrorism
China Plans Counter-bioterrorism Security System

B. MARKET ANALYTICS

Table 15. Asian Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

Table 16. Asian Historic Review for Bioterrorism Detection Equipment Market - Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart)

4. THE MIDDLE EAST

Market Analysis

Table 17. The Middle East Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

Table 18. The Middle East Historic Review for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 66 (including Divisions/Subsidiaries - 67)
Region/CountryPlayers
The United States46
Canada
Europe
France
Germany
The United Kingdom1
Rest of Europe
Asia-Pacific (Excluding Japan)4
Middle East